{"id":"https://openalex.org/W186120433","doi":null,"title":"Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease.","display_name":"Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease.","publication_year":2006,"publication_date":"2006-10-01","ids":{"openalex":"https://openalex.org/W186120433","mag":"186120433","pmid":"https://pubmed.ncbi.nlm.nih.gov/17052048","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2569765"},"language":"en","primary_location":{"id":"pmid:17052048","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17052048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Medical Association","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2569765/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079876885","display_name":"Patrick A. Griffith","orcid":"https://orcid.org/0000-0001-7077-9695","observed_orcids":["https://orcid.org/0000-0001-7077-9695"]},"institutions":[{"id":"https://openalex.org/I6332465","display_name":"Morehouse School of Medicine","ror":"https://ror.org/01pbhra64","country_code":"US","type":"education","lineage":["https://openalex.org/I6332465"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Griffith","raw_affiliation_strings":["Section of Neurology, Morehouse School of Medicine, Atlanta, GA, USA. pgriffith@mmc.edu","Section of Neurology, Morehouse School of Medicine, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Neurology, Morehouse School of Medicine, Atlanta, GA, USA. pgriffith@mmc.edu","institution_ids":["https://openalex.org/I6332465"]},{"raw_affiliation_string":"Section of Neurology, Morehouse School of Medicine, Atlanta, GA, USA","institution_ids":["https://openalex.org/I6332465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031732878","display_name":"Peter Alexander Lichtenberg","orcid":"https://orcid.org/0000-0001-6632-6714","observed_orcids":["https://orcid.org/0000-0001-6632-6714"]},"institutions":[{"id":"https://openalex.org/I4405286449","display_name":"Institute of Gerontology, The University of Tokyo","ror":"https://ror.org/025eq7064","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286449","https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Peter Lichtenberg","raw_affiliation_strings":["Institute of Gerontology, Center for Urban Responses to Environmental Stressors"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Gerontology, Center for Urban Responses to Environmental Stressors","institution_ids":["https://openalex.org/I4405286449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108411488","display_name":"ROBERT S. GOLDMAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Goldman","raw_affiliation_strings":["Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037047089","display_name":"Jennifer Payne-Parrish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jennifer Payne-Parrish","raw_affiliation_strings":["Eisai Co., LTD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Co., LTD","institution_ids":["https://openalex.org/I55881946"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0089,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.84171627,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"98","issue":"10","first_page":"1590","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.04960000142455101,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.045899998396635056,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":1.0},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/african-americans","display_name":"African Americans","score":0.984000027179718},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.7419999837875366},{"id":"https://openalex.org/keywords/memory","display_name":"memory","score":0.7300000190734863},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6830000281333923},{"id":"https://openalex.org/keywords/cibic-plus","display_name":"CIBIC-Plus","score":0.7720000147819519},{"id":"https://openalex.org/keywords/mini-mental-state-examination","display_name":"Mini-Mental State Examination","score":0.7829999923706055},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.6449999809265137}],"concepts":[{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.9411944150924683},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.5829232931137085},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5431496500968933},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.520934522151947},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4840394854545593},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.48209455609321594},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.475236177444458},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.47445568442344666},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4345613718032837},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4320042133331299},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.38567087054252625},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.34619176387786865},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077265","descriptor_name":"Donepezil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":true},{"descriptor_ui":"D001741","descriptor_name":"Black or African American","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007189","descriptor_name":"Indans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:17052048","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17052048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Medical Association","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2569765","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2569765/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Natl Med Assoc","raw_type":"Text"},{"id":"mag:186120433","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17052048","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2569765","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2569765/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Natl Med Assoc","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W38490725","https://openalex.org/W1562946553","https://openalex.org/W1847168837","https://openalex.org/W1981802311","https://openalex.org/W1982180622","https://openalex.org/W1983409607","https://openalex.org/W1994197596","https://openalex.org/W1994764156","https://openalex.org/W1997886955","https://openalex.org/W2000174679","https://openalex.org/W2002925074","https://openalex.org/W2008854521","https://openalex.org/W2018780010","https://openalex.org/W2024625353","https://openalex.org/W2030079540","https://openalex.org/W2034236657","https://openalex.org/W2037650041","https://openalex.org/W2039013375","https://openalex.org/W2039664444","https://openalex.org/W2047095305","https://openalex.org/W2050593040","https://openalex.org/W2053891882","https://openalex.org/W2055727638","https://openalex.org/W2056034609","https://openalex.org/W2057679568","https://openalex.org/W2064887457","https://openalex.org/W2065741910","https://openalex.org/W2071895473","https://openalex.org/W2081285591","https://openalex.org/W2082345650","https://openalex.org/W2084397926","https://openalex.org/W2124028685","https://openalex.org/W2148080316","https://openalex.org/W2167311298","https://openalex.org/W2417485685"],"related_works":["https://openalex.org/W2058372238","https://openalex.org/W2017888101","https://openalex.org/W2057679568","https://openalex.org/W2038762280","https://openalex.org/W1967451438","https://openalex.org/W2352318351","https://openalex.org/W2081285591","https://openalex.org/W2055414718","https://openalex.org/W127576648","https://openalex.org/W183757201"],"abstract_inverted_index":{"BACKGROUND:":[0],"African":[1,45,88,142],"Americans":[2,46,143],"have":[3,16],"a":[4,78],"higher":[5],"incidence":[6],"and":[7,40,69,72,101,125,138,147],"prevalence":[8],"of":[9,24,30,42,63,106,114,151],"Alzheimer's":[10],"disease":[11],"(AD)":[12],"than":[13],"whites":[14],"but":[15],"been":[17,82],"underrepresented":[18],"in":[19,44,95,140,153,156,159],"clinical":[20],"trials,":[21],"including":[22],"studies":[23],"cholinesterase":[25],"inhibitors.":[26],"PURPOSE:":[27],"The":[28],"purpose":[29],"this":[31],"12-week,":[32],"open-label":[33],"study":[34],"was":[35,52,110],"to":[36],"evaluate":[37],"the":[38,55,67,107,149],"efficacy":[39,155],"safety":[41],"donepezil":[43,135],"with":[47,66,86,144],"mild-to-moderate":[48,145],"AD.":[49],"METHODS:":[50],"Efficacy":[51],"assessed":[53],"via":[54],"Mini-Mental":[56],"State":[57],"Examination":[58],"(MMSE),":[59,97],"Clinician's":[60],"Interview-Based":[61],"Impression":[62],"Change-Plus":[64],"interview":[65],"patient":[68],"caregiver":[70],"(CIBIC-Plus)":[71,100],"Fuld":[73],"Object":[74],"Memory":[75],"Evaluation":[76],"(FOME),":[77],"measure":[79],"that":[80,134],"has":[81],"validated":[83],"for":[84],"use":[85],"elderly":[87],"Americans.":[89],"RESULTS:":[90],"Significant":[91],"improvements":[92],"were":[93],"observed":[94],"cognition":[96],"global":[98],"function":[99],"memory":[102],"(all":[103],"four":[104],"subscales":[105],"FOME).":[108],"Donepezil":[109],"well":[111],"tolerated;":[112],"51%":[113],"patients":[115],"experienced":[116],"adverse":[117],"events,":[118],"most":[119],"commonly":[120],"diarrhea":[121],"(5.6%),":[122],"hypertension":[123],"(5.6%)":[124],"urinary":[126],"tract":[127],"infection":[128],"(4.8%).":[129],"CONCLUSIONS:":[130],"These":[131],"results":[132],"suggest":[133],"is":[136],"effective":[137],"safe":[139],"treating":[141],"AD,":[146],"support":[148],"value":[150],"FOME":[152],"assessing":[154],"AD":[157],"trials":[158],"diverse":[160],"populations.":[161]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}